In recent years, chloramines—compounds formed when ammonia is combined with chlorine—have gained popularity as a secondary disinfectant. Chloramines are less reactive than chlorine and produce fewer harmful by-products, making them an attractive option for long-term water distribution systems. They provide sustained disinfection, reducing the risk of pathogen regrowth as water travels through pipes. However, while chloramines have advantages, they may not be as effective against certain pathogens, necessitating the need for thorough monitoring and sometimes additional treatment methods.
Another significant aspect of pharma intermediates is their role in the research and development phase of drug discovery. In the quest for new therapies, researchers often require specific intermediates to synthesize novel compounds. The ability to efficiently produce and modify these intermediates can accelerate the drug development process, facilitating the discovery of new treatments for various diseases, including cancer, diabetes, and neurological disorders.